Related Experiment Videos

Medical treatment of hepatocellular carcinoma

G Luporini¹, R Labianca, G Pancera

¹Division of Medical Oncology, San Carlo Borromeo Hospital, Milan, Italy.

Journal of Surgical Oncology. Supplement

|January 1, 1993

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

ItaLynch: an ongoing Italian study to evaluate the feasibility of mainstreaming the diagnosis of Lynch syndrome in colorectal cancer patients.

ESMO gastrointestinal oncology·2026

Overall survival with 3 or 6 months of adjuvant chemotherapy in Italian TOSCA phase 3 randomised trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2020

The prognostic impact of primary tumour location in patients with stage II and stage III colon cancer receiving adjuvant therapy. A GISCAD analysis from three large randomised trials.

European journal of cancer (Oxford, England : 1990)·2019

Consensus and controversies regarding follow-up after treatment with curative intent of nonmetastatic colorectal cancer: a synopsis of guidelines used in countries represented in the European Society of Coloproctology.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2018

The hard road to data interpretation: 3 or 6 months of adjuvant chemotherapy for patients with stage III colon cancer?

Annals of oncology : official journal of the European Society for Medical Oncology·2018

Dihydropyrimidine dehydrogenase pharmacogenetics for predicting fluoropyrimidine-related toxicity in the randomised, phase III adjuvant TOSCA trial in high-risk colon cancer patients.

British journal of cancer·2017

See all related articles